CAMBREX CORP·4

Aug 7, 5:55 PM ET

Hanley Samantha 4

4 · CAMBREX CORP · Filed Aug 7, 2018

Insider Transaction Report

Form 4
Period: 2018-08-06
Hanley Samantha
Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2018-08-06$40.65/sh+6,250$254,06327,500 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-06+3,7503,750 total
    Exercise: $22.50Exp: 2022-01-28Common Stock (3,750 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-06+12,50012,500 total
    Exercise: $41.35Exp: 2022-10-21Common Stock (12,500 underlying)
  • Exercise/Conversion

    Common Stock

    2018-08-06$41.35/sh+12,500$516,93721,250 total
  • Sale

    Common Stock

    2018-08-06$63.38/sh7,600$481,6880 total
  • Exercise/Conversion

    Common Stock

    2018-08-06$16.91/sh+2,500$42,2632,500 total
  • Exercise/Conversion

    Common Stock

    2018-08-06$17.81/sh+2,500$44,5255,000 total
  • Exercise/Conversion

    Common Stock

    2018-08-06$22.50/sh+3,750$84,3568,750 total
  • Sale

    Common Stock

    2018-08-06$62.36/sh19,900$1,240,9647,600 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-06+2,5000 total
    Exercise: $16.91Exp: 2020-10-28Common Stock (2,500 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-06+2,5002,500 total
    Exercise: $17.81Exp: 2021-10-22Common Stock (2,500 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-06+6,25018,750 total
    Exercise: $40.65Exp: 2023-10-26Common Stock (6,250 underlying)
Footnotes (7)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.95 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.05 to $63.68 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.
  • [F3]The option representing a right to purchase 10,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted
  • [F4]The option representing a right to purchase 10,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted
  • [F5]The option representing a right to purchase 15,000 shares became exercisable in four equal installments beginning January 28, 2016, which was the first anniversary of the date on which the option was granted
  • [F6]The option representing a right to purchase 25,000 shares became exercisable in four equal installments beginning October 21, 2016, which was the first anniversary of the date on which the option was granted
  • [F7]The option representing a right to purchase 25,000 shares became exercisable in four equal installments beginning October 26, 2017, which was the first anniversary of the date on which the option was granted

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION